CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025
The Indian drug regulator has approved the highest number of new drugs based on r-DNA origin, both for imports and manufacturing in the country during the year 2025, compared to…
Cipla launches inhalable insulin for diabetes care
New Delhi, Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central…
CCRAS Conducting Clinical Studies On Eight Drugs
New Delhi : The Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous body under the Ministry of Ayush, is conducting clinical studies on eight drugs while nine others have…








